Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
NCT06730503
·
clinicaltrials.gov ↗
RECRUITING
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Immune checkpoint inhibitor
Sponsor
Shanghai Chest Hospital